Active, not recruitingNCT06128824
High Frequency Imaging in Cerebral Amyloid Angiopathy
Studying Hereditary cerebral amyloid angiopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Martin Dichgans
- Principal Investigator
- Marco Duering, MDInstitute for Stroke and Dementia Research
- Intervention
- MR Imaging(other)
- Enrollment
- 75 enrolled
- Eligibility
- 50 years · All sexes
- Timeline
- 2019 – 2026
Study locations (3)
- DZNE/Bonn - Klinik und Poliklinik für Neurologie, Universitätsklinikum Bonn, Bonn, Germany
- DZNE/Magdeburg - Universitätsklinikum Magdeburg, Magdeburg, Germany
- Insitute for Stroke and Dementia Research, Munich, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06128824 on ClinicalTrials.govOther trials for Hereditary cerebral amyloid angiopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06714097Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGPHASE2NCT05709314A Study of AMDX-2011P in Participants With CAAAmydis Inc.
- RECRUITINGPHASE2NCT06393712A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid AngiopathyAlnylam Pharmaceuticals
- RECRUITINGNCT04204642SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta